London shares experienced a modest rise on Friday, supported by advancements in drugmaker AstraZeneca, as investors monitored important U.S. inflation data that could impact the Federal Reserve’s rate decision in the coming week. The blue-chip index experienced an uptick of 0.2% by 11:05, while the midcap index climbed 0.4%. Both indices seemed ready to wrap Read More
AstraZeneca
On Wednesday, London’s FTSE 100 index experienced a slight decline following two consecutive sessions of record high closures, primarily influenced by losses in the industrials and energy sectors. The blue-chip index was down 0.1% at 9,886 points as of 1214, yet it remains close to record levels and within reach of the 10,000 mark. The Read More

